Abstract:The establishment of human embryonic stem cell (hESC) lines has generated a great deal of excitement in the fields of stem cell biology and regenerative medicine. It has been hoped that hESCs and somatic stem cells could be potential sources of cells to regenerate or rejuvenate damaged tissues. Yet studies on the biology of hESCs have been hindered by difficulties in manipulating this type of cells in culture in vitro. This is largely due to lack of full understanding of the molecular and cellular basis for maintenance of hESC pluripotency. Since mESCs have received extensive attentions in the past two decades and relatively more information is available, characterization of hESCs has been naturally conducted by referencing mESC properties. Recent studies from a number of laboratories have suggested distinct biological properties and molecular signaling mechanisms between human and mouse embryonic stem cells (hESCs and mESCs). Here we report that Shp2, an intracellular tyrosine phosphatase with two SH2 domains, has a conserved role in promoting signals resulting in differentiation of both hESCs and mESCs. Homozygous ablation of Shp2 in mESCs resulted in impaired differentiation into all three germ layer cell lineages accompanied by improved self-renewal. siRNA-mediated Shp2 knockdown in hESCs resulted in a very similar phenotype of impaired differentiation. Furthermore, small molecule inhibitors for Shp2 enzyme suppressed both hESC and mESC differentiation in vitro. Shp2 modulates LIF and BMP signals flowing through Erk, Stat3 and Smad pathways in mESCs and also regulates FGF and BMP signaling through the Erk and Smad pathways in hESCs. These results reveal a common signaling mechanism shared by hESCs and mESCs via Shp2 modulation of overlapping and distinct pathways. Pharmaceutical intervention of Shp2 activity might be a practical means for amplification of hESCs in vitro.

Smad7 Enables STAT3 Activation and Promotes Pluripotency Independent of TGF-β Signaling

Tumor suppressor bromodomain-containing protein 7 cooperates with Smads to promote transforming growth factor-β responses

Modulation of STAT3 phosphorylation by PTPN2 inhibits naïve pluripotency of embryonic stem cells.

Stat3 Activation is Critical for Pluripotency Maintenance

STAT3 phosphorylation at tyrosine 705 and serine 727 differentially regulates mouse ESC fates.

Prdm14 Promotes Mouse ESC Self-Renewal and PGCLC Specification Through Enhancement of Stat3 Activity

Pim2 Regulates Stemness Through Phosphorylation of 4E-Bp1

A conserved mechanism for control of human and mouse embryonic stem cell pluripotency and differentiation by shp2 tyrosine phosphatase.

Smad7: Not Only a Regulator, but Also a Cross-Talk Mediator of TGF-β Signalling

STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling.

LIF Promotes Sec15b‐Mediated STAT3 Exosome Secretion to Maintain Stem Cell Pluripotency in Mouse Embryonic Development

Smad7 Antagonizes Transforming Growth Factor Β Signaling in the Nucleus by Interfering with Functional Smad-DNA Complex Formation

A Conserved Role of Shp2 in Regulation of Human and Mouse Es Cell Differentiation

Linc1557 is Critical for the Initiation of Embryonic Stem Cell Differentiation by Directly Targeting the LIF/STAT3 Signaling Pathway.

Wnt/β-catenin and LIF–Stat3 Signaling Pathways Converge on Sp5 to Promote Mouse Embryonic Stem Cell Self-Renewal

Smad2 Mediates Activin/Nodal Signaling in Mesendoderm Differentiation of Mouse Embryonic Stem Cells

Arginine methylation of SMAD7 by PRMT1 in TGF-β–induced epithelial–mesenchymal transition and epithelial stem-cell generation

STAT3 Selectively Interacts with Smad3 to Antagonize TGF-β

LncRNA-Smad7 mediates cross-talk between Nodal/TGF-β and BMP signaling to regulate cell fate determination of pluripotent and multipotent cells

GPR160 Regulates the Self-Renewal and Pluripotency of Mouse Embryonic Stem Cells Via JAK1/STAT3 Signal Pathway